| Bioactivity | Verlukast is a potent, selective, and orally active antagonist of leukotriene receptor. Verlukast has the potential for the research of asthma[1]. |
| Target | leukotriene receptor |
| Name | Verlukast |
| CAS | 120443-16-5 |
| Formula | C26H27ClN2O3S2 |
| Molar Mass | 515.09 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Dahlén B, et al. Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects. Thorax. 1993;48(12):1205-1210. |
Verlukast
CAS: 120443-16-5 F: C26H27ClN2O3S2 W: 515.09
Verlukast is a potent, selective, and orally active antagonist of leukotriene receptor. Verlukast has the potential for
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.